Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
KURA compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
KURA
Kura Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
KURA
Kura Oncology, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
KURA, solid
LLY, dashed
KURA
Kura Oncology, Inc.
Change
6.78
· pre 6.76
· delayed
Mkt cap
$604.9M
Revenue
$21M
Q2 FY26
Revenue
$67M
FY25
LLY
ELI Lilly & Co
Change
1,371.32
· pre 1,343.68
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
KURA
Kura Oncology, Inc.
vs
LLY
ELI Lilly & Co
6.78
pre 6.76
delayed
Price
1,371.32
pre 1,343.68
delayed
$604.9M
Mkt cap
$1.2T
Q2 FY26
$21M
Revenue
$24.4B
Q3 FY26
FY25
$67M
Revenue
$65.2B
FY25
Change
Change
KURA
6.78
vs
LLY
1,371.32
Pre-market
Nov 6 '26
delayed